﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2017v2.3">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2018-10-10T08:48:57-05:00</ReturnTs>
    <TaxPeriodEndDt>2017-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>271728945</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PKF O'CONNOR DAVIES LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>665 FIFTH AVENUE</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10022</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2017-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>133859563</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE ZACHARY &amp; ELIZABETH M FISHER CENTER</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOR ALZHEIMER'S RESEARCH FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ZACH</BusinessNameControlTxt>
      <PhoneNum>2129151321</PhoneNum>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET NO 16 FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>KENT KAROSEN</PersonNm>
      <PersonTitleTxt>PRESIDENT &amp; CEO</PersonTitleTxt>
      <PhoneNum>2129151321</PhoneNum>
      <SignatureDt>2018-10-10</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>GARRETT M HIGGINS</PreparerPersonNm>
      <PTIN>P00543209</PTIN>
      <PhoneNum>2122862600</PhoneNum>
      <PreparationDt>2018-10-08</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2017</TaxYr>
    <BuildTS>2022-09-23 18:48:47Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>ALZHEIMER'S RESEARCH FDNFISHER CTR</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfficerNm>KENT KAROSEN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET NO 16 FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>12624402</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ALZINFO.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1995</FormationYr>
      <LegalDomicileStateCd>NY</LegalDomicileStateCd>
      <ActivityOrMissionDesc>SEE SCHEDULE O.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>16</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>14</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>9</TotalEmployeeCnt>
      <TotalVolunteersCnt>15</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>4376335</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>6064311</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>552782</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>1739866</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>2156</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>1790</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>4931273</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>7805967</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>6744376</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>3298278</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>909840</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>896563</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>240488</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>458435</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>433612</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>8112651</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>4628453</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-3181378</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>3177514</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>23863565</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>27353916</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>4718230</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>4114782</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>19145335</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>23239134</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>SEE SCHEDULE O.THE ZACHARY AND ELIZABETH M. FISHER ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3-PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE; IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES; AND FINDING A CURE FOR THIS DEVASTATING DISEASE.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>3113278</ExpenseAmt>
      <GrantAmt>3113278</GrantAmt>
      <Desc>A GRANT WAS MADE TO THE FISHER CENTER FOR ALZHEIMER'S RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS. THE LAB IS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHO HEADS A TEAM OF OVER 50 INTERNATIONALLY RENOWNED SCIENTISTS. HIS SEMINAL FINDINGS HAVE BEEN THE BASIS OF MANY OF TODAY'S ALZHEIMER'S INVESTIGATIONS WORLDWIDE.IN 2017, FISHER SCIENTISTS CONTINUED THEIR EFFORT TO OPTIMIZE DERIVATIVES (CHEMICALLY ALTERED FORMS) OF GLEEVEC AND TEST THE NEW DERIVATIVES FOR MORE POTENT BETA-AMYLOID LOWERING ACTIVITY. THE NEW COMPOUNDS WERE ALSO TESTED FOR THEIR ABILITY TO ACCUMULATE IN THE BRAIN WITHOUT BEING PUMPED OUT BY THE BLOOD-BRAIN-BARRIER, A WEAKNESS OF THE ORIGINAL GLEEVEC MOLECULE. INTERESTINGLY, MUTATIONS THAT PROTECT PEOPLE FROM DEVELOPING AD HAVE BEEN DESCRIBED IN THE LITERATURE. MECHANISTICALLY, SOME OF THE GLEEVEC DERIVATIVES NEWLY SYNTHETIZED SEEM TO MIMIC THE EFFECT OF ONE SUCH PROTECTIVE MUTATION CALLED A673T. THE FISHER SCIENTISTS HAVE NOW STUDIED IN GREAT DETAILS THE CELLULAR PROCESS UNDERLYING THE PROTECTIVE EFFECT OF THIS MUTATION. THIS RECENT WORK IS ALSO SUGGESTING THAT DRUGS TARGETING THIS PATHWAY MIGHT PROVIDE PROTECTION AGAINST THE DEVELOPMENT OF AD.IN OTHER RESEARCH, THE SCIENTISTS ACCELERATED THE BREAKDOWN OF THE TOXIC BETA-AMYLOID COMPONENT BY TARGETING A CELLULAR PROCESS CALLED AUTOPHAGY. IT IS A BIOLOGICAL FUNCTION RESPONSIBLE FOR REMOVING DEBRIS FROM THE CELLS, INCLUDING UNWANTED MATERIALS SUCH AS THE PROTEIN AGGREGATES SUCH AS AMYLOID PRODUCTS. THE SCIENTISTS IDENTIFIED A NOVEL SIGNALING NETWORK WITHIN NEURONS THAT REGULATES BETA-AMYLOID DEGRADATION. FURTHERMORE, THEY DEMONSTRATED THAT THE PHOSPHORYLATION OF PS1 (A KEY COMPONENT FOR THE PRODUCTION OF THE TOXIC BETA-AMYLOID PEPTIDE) BY THE PROTEIN KINASE CK1 PARTICIPATES IN THE DEGRADATION OF INTRACELLULAR MATERIAL.AN IMPORTANT CONCEPT HAS BEEN EMERGING IN THE FIELD OF ALZHEIMER'S DISEASE WITHIN THE LAST FEW YEARS, THE NOTION OF SELECTIVE NEURONAL VULNERABILITY. THIS CONCEPT IMPLICATES THAT SPECIFIC TYPES OF NERVE CELLS (NEURONS) WILL BE MORE SUSCEPTIBLE TO A PATHOLOGICAL PROCESS, THEY WILL BE AFFECTED AND DISAPPEAR SOONER THAN OTHERS AND THUS BE CALLED RESISTANT NEURONS. IN THE CASE OF AD, IT IS WELL KNOWN BASED ON HUMAN POST MORTEM STUDIES THAT SPECIFIC NEURONAL TYPES DISAPPEAR BEFORE OTHERS, WHILE SOME OTHER TYPES SEEM TO BE RESISTANT TO THE DISEASE PROCESS. UNDERSTANDING WHY SOME CELLS ARE VULNERABLE AND OTHERS ARE RESISTANT TO THE DISEASE PROCESS WILL CERTAINLY BRING NEW CLUES ON THE UNDERLYING CAUSES OF THE DISEASE AND HELP DESIGN ENTIRELY NEW THERAPEUTIC STRATEGIES. TO PURSUE THEIR EFFORT IN THAT DIRECTION, FISHER SCIENTISTS ARE USING A UNIQUE SET OF TOOLS AND TECHNOLOGIES THAT THEY DEVELOPED OVER THE YEARS. THEY DISCOVERED DOZENS OF NEW GENES THAT ARE LINKED TO THE VULNERABILITY AND THEY ARE CURRENTLY CHARACTERIZING THESE GENES, GIVING A SPECIAL EMPHASIS ON GENES THAT COULD BE TARGETED THERAPEUTICALLY. LASTLY, THE FISHER SCIENTISTS ARE STUDYING A TYPE OF CELL CALLED MICROGLIA. THESE CELLS FUNCTION, IN THE CENTRAL NERVOUS SYSTEM, AS SCAVENGERS. MICROGLIA CONTRIBUTES TO AD PATHOGENESIS AND SEEMS TO HAVE VARIOUS ROLES, SEVERAL OF THEM RELATED TO INFLAMMATION, BUT THE MECHANISMS BY WHICH MICROGLIA, AND INFLAMMATION IN GENERAL, BECOME DYSFUNCTIONAL IN AD REMAIN OBSCURE. THE FISHER SCIENTISTS HAVE SHOWN THAT THEY CAN MODULATE AD-LIKE HALLMARKS BY MANIPULATING IN VIVO THE ACTIVITY OF PRESENILIN 1. THEY HAVE ALSO SHOWN USING DIFFERENT TECHNIQUES THAT PRESENILIN 1 PLAYS A CRUCIAL ROLE DURING MICROGLIAL DEVELOPMENT AS WELL AS FOR SYNAPTIC TRANSMISSION. A GRANT WAS MADE TO THE ROCKEFELLER UNIVERSITY TO ESTABLISH THE PAUL GREENGARD PROFESSORSHIP IN NEUROSCIENCE TO RECOGNIZE NOBEL LAUREATE DR. PAUL GREENGARD, DIRECTOR OF THE FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION AND HIS MANY YEARS OF DEDICATION IN THE FIGHT AGAINST ALZHEIMER'S. THE PURPOSE OF THE GREENGARD PROFESSORSHIP IS TO ENSURE A CONTINUED COMMITMENT TO THE OUTSTANDING RESEARCH BY THE FISHER CENTER FOR ALZHEIMER'S RESEARCH LAB. THE PROFESSORSHIP, ESTABLISHED IN PERPETUITY, WILL BE HELD BY AN OUTSTANDING SENIOR SCIENTIST AT THE ROCKEFELLER UNIVERSITY WORKING IN THE FIELD OF ALZHEIMER'S RESEARCH. THE $5 MILLION GRANT WILL BE PAID TO THE GREENGARD PROFESSORSHIP OVER 7 YEARS. AS PER COMMITMENT MADE LAST YEAR IN 2016, FISHER CENTER FOUNDATION HAS PAID THE FIRST INSTALLMENT OF $715,000.00 THIS YEAR.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>868492</ExpenseAmt>
        <Desc>THE FISHER CENTER ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC AWARENESS AND EDUCATION ABOUT ALZHEIMER'S AND INFORMATION ON CAREGIVING. THE PROGRAM USES BOTH ONLINE AND TRADITIONAL MEDIA CONDUITS TO KEEP THE PUBLIC INFORMED WITH COMPREHENSIVE INFORMATION ABOUT ALZHEIMER'S, RECENT RESEARCH STUDIES, TREATMENTS AND DISEASE MANAGEMENT APPROACHES THROUGH ITS PUBLICATION, PRESERVING YOUR MEMORY MAGAZINE (CIRCULATION: 50,502; PUBLISHED THREE TIMES A YEAR, WITH AN ESTIMATED READERSHIP OF ALMOST ONE MILLION ANNUALLY), WHICH IS DISTRIBUTED TO HEALTH CARE AND COMMUNITY ORGANIZATIONS NATIONWIDE. THE FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION HAS A WEBSITE (ALZINFO.ORG) AND DISTRIBUTES BIWEEKLY E-NEWSLETTERS OF EXPERT-REVIEWED ALZHEIMER'S NEWS AND RESEARCH TO OVER 26,900 SUBSCRIBERS. THE WEBSITE IS UPDATED REGULARLY WITH FRESH CONTENT ON ALZHEIMER'S, CAREGIVING AND RESEARCH. IN 2017, THE WEBSITE HAD 665,089 UNIQUE VISITORS. FURTHERMORE, OUR SOCIAL PLATFORMS HAVE A COMBINED REACH OF OVER 43,000 FOLLOWERS.THE FOUNDATION ALSO PUBLISHED A NEW BOOK, "WHY CAN'T GRANDMA REMEMBER MY NAME?", WRITTEN BY FOUNDATION PRESIDENT KENT L. KAROSEN AND CO-AUTHORED BY CHANA STIEFEL. THE BOOK EXPLAINS ALZHEIMER'S DISEASE BY INTEGRATING ARTWORK CREATED BY CHILDREN JUXTAPOSED WITH ART CREATED BY ALZHEIMER'S PATIENTS, DEMONSTRATING THE POWER OF ART THERAPY FOR ALL AGES AND A WAY FOR PARENTS AND FAMILY TO SHARE WITH A YOUNGER AUDIENCE WHAT IS HAPPENING TO GRANDMA OR OTHER LOVED ONES.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>125000</ExpenseAmt>
        <GrantAmt>125000</GrantAmt>
        <Desc>A GRANT WAS MADE TO THE FISHER ALZHEIMER'S DISEASE PROGRAM AT THE FISHER PROGRAM AT NEW YORK UNIVERSITY SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICIENCY OF BOTH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT OPTIONS FOR ALZHEIMER'S DISEASE. THE CENTER IN UNDER THE DIRECTION OF DR. BARRY REISBERG, M.D., INTERNATIONALLY KNOWN EXPERT IN THE CARE OF ALZHEIMER'S PATIENTS. THE TOOLS AND SCALE FOR RESEARCH EVALUATION AND DISEASE MANAGEMENT DEVELOPED BY THIS PROGRAM ARE USED IN CARE SETTING AROUND THE WORLD. DR. REISBERG AND HIS COLLEAGUES AT THE CENTER HAVE PUBLISHED NUMEROUS ARTICLES ON BEST CARE MODALITIES THAT MAY SLOW THE PROGRESSION AND IMPROVE THE QUALITY OF LIFE FOR THOSE WITH ALZHEIMER'S IN 2017, THE FISHER PROGRAM AT NEW YORK UNIVERSITY SCHOOL OF MEDICINE (THE FISHER PROGRAM AT NYUSOM) MADE MAJOR PROGRESS IN OUR RESEARCH AND IN DISSEMINATING OUR FINDINGS AS A RESULT OF FISHER FOUNDATION SUPPORT. THE FISHER PROGRAM AT NYUSOM PUBLISHED A PAPER DESCRIBING THE PRECISE METHODOLOGY FOR THE APPLICATION OF THE SCIENCE OF AD MANAGEMENT (REISBERG, B., KENOWSKY, S., COMPREHENSIVE, INDIVIDUALIZED, PERSON-CENTERED MANAGEMENT OF COMMUNITY-RESIDING PERSONS WITH MODERATE-TO-SEVERE ALZHEIMER'S DISEASE: A RANDOMIZED CONTROLLED TRIAL. DEMENT GERIATR COGN DISORD, 2017; 43:100-117). THE FISHER PROGRAM AT NYUSOM ACHIEVED AN EFFECT WITH THE MANAGEMENT PROGRAM, WHICH GLOBALLY, WAS 10 TIMES THE EFFECT, SEEN WITH THE MEDICATION, MEMANTINE. THE FISHER PROGRAM AT NYUSOM PREPARED A NATIONAL INSTITUTES OF HEALTH ONLINE PUBMED SCIENTIFIC REPORT OF THIS PUBLICATION WHICH SERVES TO MAKE THE REPORT WIDELY AND FREELY AVAILABLE TO BOTH THE SCIENTIFIC COMMUNITY, AND THE PUBLIC. THE FISHER PROGRAM AT NYUSOM PUBLISHED A 59-PAGE CHAPTER, REISBERG, B., ET AL., ALZHEIMER'S DISEASE. IN: MEDICAL ASPECTS OF DISABILITY, 5TH EDITION, A. MOROZ, S. R. FLANAGAN, AND H. ZARETSKY (EDS.), NEW YORK, SPRINGER, 2017, P. 31-90 DESCRIBING ALZHEIMER'S MANAGEMENT. THE FISHER PROGRAM AT NYUSOM ANALYZED THE MAGNITUDE OF THE EFFECT ON FUNCTIONING OF THE CI-PCM PROGRAM AND FOUND AN EFFECT, WHICH WAS 750% GREATER THAN THE EFFECT, WHICH THE FISHER PROGRAM AT NYUSOM HAD SEEN WITH MEMANTINE TREATMENT ALONE IN THE PIVOTAL NEJM MEMANTINE STUDY (REISBERG ET AL., NEW ENGLAND JOURNAL OF MEDICINE, 2003). DR. KENOWSKY PRESENTED THESE RESULTS AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC), IN JULY, 2017, IN LONDON (U.K.), AS PART OF A FEATURED RESEARCH SESSION, CHAIRED BY DRS. REISBERG AND JISKA COHEN-MANSFIELD ENTITLED, "ECOPSYCHOSOCIAL TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS: CURRENT ADVANCES". OUR FINDINGS THE FISHER PROGRAM AT NEW YORK UNIVERSITY SCHOOL OF MEDICINERE THEN PUBLISHED (KENOWSKY, S.,REISBERG, B., A COMPREHENSIVE, INDIVIDUALIZED, PERSON-CENTERED MANAGEMENT PROGRAM IN SUBJECTS TREATED WITH MEMANTINE, ENHANCES FUNCTIONING BY 750%, IN COMPARISON WITH MEMANTINE TREATMENT ALONE IN PERSONS WITH MODERATE-TO-SEVERE AD IN 28-THE FISHER PROGRAM AT NEW YORK UNIVERSITY SCHOOL OF MEDICINEEK RANDOMIZED CONTROLLED TRIALS, ALZHEIMER'S AND DEMENTIA,13 (7), SUPPLEMENT, P173, 2017). THIS PRESENTATION RESULTED IN WIDESPREAD PUBLICITY INCLUDING: NATIONAL PUBLIC RADIO, "SCIENCE FRIDAY", JULY 21, 2017 SEGMENT, HTTPS://WWW.SCIENCEFRIDAY.COM/SEGMENTS/MORE- COMPREHENSIVE-PATIENT-CARE-CAN-SLOW-SYMPTOMS-OF-ALZHEIMERS/; PUBLIC RADIO INTERNATIONAL, SLOWING THE SYMPTOMS OF ALZHEIMER'S BY HELPING PATIENTS RELEARN LOST SKILLS, AUGUST 12, 2017, HTTPS://WWW.PRI.ORG/STORIES/2017-08-12/SLOWING- SYMPTOMS-ALZHEIMER-S-HELPING-PATIENTS-RELEARN-LOST-SKILLS; SIRIUSXM, "DR. RADIO," CHANNEL 110, HEALTHY AGING, RECENT FINDINGS REPORTED AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE REGARDING ADVANCES IN THE MANAGEMENT OF ALZHEIMER'S DISEASE, 7/31/2017. THE FISHER PROGRAM AT NYUSOM ANALYZED ADDITIONAL RESULTS AND PRESENTED THEM AT THE AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY, 56TH ANNUAL MEETING, IN PALM SPRINGS, CALIFORNIA IN DECEMBER 3-7, 2017. THE FISHER PROGRAM AT NYUSOM FOUND THAT THE VERY LARGE EFFECTS OF THE COMPREHENSIVE, INDIVIDUALIZED, PERSON-CENTERED MANAGEMENT (CI-PCM) PROGRAM ON PERSONS WITH MODERATELY-SEVERE ALZHEIMER'S DISEASE (AD), THE FISHER PROGRAM AT NYUSOM NOT ATTRIBUTED TO DIFFERENTIAL ANTIPSYCHOTIC USAGE. IN SUMMARY, THE FISHER PROGRAM AT NYUSOM HAS MADE SIGNIFICANT ADVANCES IN DEMONSTRATING THE VALUE OF SCIENTIFICALLY BASED MANAGEMENT AND CARE OVER THIS LAST YEAR. HOPEFULLY, THESE ADVANCES WILL TRANSLATE INTO IMPROVED CARE, AND IMPROVED HEALTH AND THE NEW YORK UNIVERSITY SCHOOL OF WELLBEING, FOR AD PERSONS AND THEIR CARE PROVIDERS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>60000</ExpenseAmt>
        <GrantAmt>60000</GrantAmt>
        <Desc>OTHER PROGRAM EXPENSES:</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>60000</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcGrantAmt>60000</TotalOtherProgSrvcGrantAmt>
      <TotalProgramServiceExpensesAmt>4166770</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>9</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>16</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>14</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AZ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TX</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>FEKADU TADDESE</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>2129151324</PhoneNum>
        <USAddress>
          <AddressLine1Txt>110 EAST 42ND STREET FL 16</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARRY SLOANE</PersonNm>
        <TitleTxt>CHAIRMAN/TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HOWARD LUTNICK</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARTIN EDELMAN</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO</TitleTxt>
        <AverageHoursPerWeekRt>30.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>272879</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MURRAY RUBIN</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MANNY ALVAREZ</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR E RATCLIFFE ANDERSON JR</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GERRY BYRNE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HADLEY FISHER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BETSY GOTBAUM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR PAUL GREENGARD</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES L NEDERLANDER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD J SALEM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MOSHE SHIKE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID HW TURNER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LOIS WHITMAN-HESS</PersonNm>
        <TitleTxt>TRUSTEE (AS OF 5/2017)</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CORY RYAN</PersonNm>
        <TitleTxt>SENIOR VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>117791</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>13694</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>390670</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>13694</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>STAYWELL COMPANY LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>407 NORWALK STREET</AddressLine1Txt>
            <CityNm>GREENSBORO</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27407</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MAGAZINE PUBLISHING</ServicesDesc>
        <CompensationAmt>187513</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <FederatedCampaignsAmt>303536</FederatedCampaignsAmt>
      <AllOtherContributionsAmt>5760775</AllOtherContributionsAmt>
      <NoncashContributionsAmt>98398</NoncashContributionsAmt>
      <TotalContributionsAmt>6064311</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>331693</TotalRevenueColumnAmt>
        <ExclusionAmt>331693</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>6226608</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>4818435</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>1408173</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>1408173</TotalRevenueColumnAmt>
        <ExclusionAmt>1408173</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS REVENUE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1790</TotalRevenueColumnAmt>
        <ExclusionAmt>1790</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>1790</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>7805967</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>1741656</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>3248278</TotalAmt>
        <ProgramServicesAmt>3248278</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>50000</TotalAmt>
        <ProgramServicesAmt>50000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>335379</TotalAmt>
        <ProgramServicesAmt>251534</ProgramServicesAmt>
        <ManagementAndGeneralAmt>33538</ManagementAndGeneralAmt>
        <FundraisingAmt>50307</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>475311</TotalAmt>
        <ProgramServicesAmt>318017</ProgramServicesAmt>
        <ManagementAndGeneralAmt>33537</ManagementAndGeneralAmt>
        <FundraisingAmt>123757</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>6834</TotalAmt>
        <ProgramServicesAmt>4573</ProgramServicesAmt>
        <ManagementAndGeneralAmt>482</ManagementAndGeneralAmt>
        <FundraisingAmt>1779</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>40436</TotalAmt>
        <ProgramServicesAmt>26669</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2812</ManagementAndGeneralAmt>
        <FundraisingAmt>10955</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>38603</TotalAmt>
        <ProgramServicesAmt>25828</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2724</ManagementAndGeneralAmt>
        <FundraisingAmt>10051</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>29807</TotalAmt>
        <ManagementAndGeneralAmt>29807</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>24000</TotalAmt>
        <ManagementAndGeneralAmt>24000</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>49119</TotalAmt>
        <ManagementAndGeneralAmt>49119</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>199513</TotalAmt>
        <ProgramServicesAmt>199513</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>9950</TotalAmt>
        <FundraisingAmt>9950</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>48695</TotalAmt>
        <ProgramServicesAmt>527</ProgramServicesAmt>
        <ManagementAndGeneralAmt>18140</ManagementAndGeneralAmt>
        <FundraisingAmt>30028</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>13511</TotalAmt>
        <ProgramServicesAmt>13511</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>40648</TotalAmt>
        <ProgramServicesAmt>28320</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8667</ManagementAndGeneralAmt>
        <FundraisingAmt>3661</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>344</TotalAmt>
        <ManagementAndGeneralAmt>344</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>559</TotalAmt>
        <ManagementAndGeneralAmt>559</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>10961</TotalAmt>
        <ManagementAndGeneralAmt>10961</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>6505</TotalAmt>
        <ManagementAndGeneralAmt>6505</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>4628453</TotalAmt>
        <ProgramServicesAmt>4166770</ProgramServicesAmt>
        <ManagementAndGeneralAmt>221195</ManagementAndGeneralAmt>
        <FundraisingAmt>240488</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>987114</BOYAmt>
        <EOYAmt>2009489</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>7343848</BOYAmt>
        <EOYAmt>8019273</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>1957127</BOYAmt>
        <EOYAmt>1137899</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <LandBldgEquipCostOrOtherBssAmt>9436</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>8504</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>1491</BOYAmt>
        <EOYAmt>932</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>13573985</BOYAmt>
        <EOYAmt>16186323</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>23863565</BOYAmt>
        <EOYAmt>27353916</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>123854</BOYAmt>
        <EOYAmt>122128</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>4594376</BOYAmt>
        <EOYAmt>3992654</EOYAmt>
      </GrantsPayableGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>4718230</BOYAmt>
        <EOYAmt>4114782</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>18637431</BOYAmt>
        <EOYAmt>22839239</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>507904</BOYAmt>
        <EOYAmt>399895</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>19145335</BOYAmt>
        <EOYAmt>23239134</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>23863565</BOYAmt>
        <EOYAmt>27353916</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>3177514</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>996435</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>-80150</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>4872354</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3213554</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>3248678</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>4377975</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>6064311</CurrentTaxYearAmt>
        <TotalAmt>21776872</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>4872354</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3213554</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>3248678</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>4377975</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>6064311</CurrentTaxYearAmt>
        <TotalAmt>21776872</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>2465161</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>19311711</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>308109</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>392203</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>491655</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>350202</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>331693</CurrentTaxYearAmt>
        <TotalAmt>1873862</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus1YearAmt>1336</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1790</CurrentTaxYearAmt>
        <TotalAmt>3126</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>23653860</TotalSupportAmt>
      <PublicSupportCY170Pct>0.81640</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.82670</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:</FormAndLineReferenceDesc>
        <ExplanationTxt>MISCELLANEOUS - 2016 AMOUNT: $ 1,336. 2017 AMOUNT: $ 1,790.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>9436</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>8504</DepreciationAmt>
        <BookValueAmt>932</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>932</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>9107261</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>996435</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>353978</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>1350413</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>7756848</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>49119</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>49119</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>7805967</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>5013462</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>353978</DonatedServicesUseFcltsAmt>
      <OtherExpensesIncludedAmt>80150</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>434128</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>4579334</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>49119</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>49119</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>4628453</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES - THE FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR TAX YEARS PRIOR TO 2014.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>UNCOLLECTIBLE PLEDGES 80,150.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTS</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>50000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>50000</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>50000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE TRANSFER</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH WILL BE CARRIED OUT BY THE KAROLINSKA INSTITUTE UNDER THE DIRECTION OF DR. PER SVENNINGSSON TO ELUCIDATE THE MOLECULAR MECHANISMS OF THE ACTION IN THE BRAIN RELATING TO THE CAUSE AND TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S DISEASE. THE FOUNDATION REQUIRES THE GRANTEE TO SUBMIT AN INTERIM 6-MONTH REPORT ON THE PROGRESS OF THEIR INVESTIGATIONS AS WELL AS A FINAL REPORT UPON COMPLETION OF THE TERM OF THE AGREEMENT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR ITS FOREIGN EXPENDITURES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE ROCKEFELLER UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1230 YORK AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10021</ZIPCd>
        </USAddress>
        <RecipientEIN>131624158</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>3113278</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NYU MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>550 FIRST AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10016</ZIPCd>
        </USAddress>
        <RecipientEIN>135562308</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>125000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PAT SUMMIT FOUNDATION</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>520 W SUMMIT HILL DRIVE STE 1101</AddressLine1Txt>
          <CityNm>KNOXVILLE</CityNm>
          <StateAbbreviationCd>TN</StateAbbreviationCd>
          <ZIPCd>37902</ZIPCd>
        </USAddress>
        <RecipientEIN>620807696</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>10000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>3</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MONITORS THE USE OF GRANT FUNDS IN THE US BY RECEIVING PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED AS A RESULT OF THIS FUNDING. THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY SUBMITS A REPORT AT EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. THE FISHER EDUCATIONAL AND RESOURCES PROGRAM AT NYU SCHOOL OF MEDICINE REPORTS AT THE END OF THE FUNDING PERIOD IN THEIR REQUEST FOR FURTHER FUNDING ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES SUPPORTED BY THE FOUNDATION. THE FOUNDATION FUNDING DECISIONS ARE MADE UNDER THE SOLE AND ABSOLUTE DISCRETION OF THE BOARD PURSUANT TO A MAJORITY VOTE. A SCIENCE ADVISORY BOARD COMPRISED OF MEDICAL AND SCIENTIFIC EXPERTS IN THE FIELD OF ALZHEIMER'S DISEASE AND RELATED DISEASES ADVISES AND ASSISTS THE FOUNDATION IN CONNECTION WITH FUNDING GRANT REQUESTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE I, PART II, COLUMN (H):</FormAndLineReferenceDesc>
        <ExplanationTxt>PURPOSE OF GRANT THE ROCKEFELLER UNIVERSITY: GRANTS TO THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS AND TO SUPPORT PROFESSORSHIP TO CONDUCT RESEARCH ACTIVITIES. NYU MEDICAL CENTER: NYU GRANT TO FISHER EDUCATION AND RESOURCES PROGRAM AT NY UNIVERSITY SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF MEMANTINE AND COMPREHENSIVE INDIVIDUALIZED PATIENT-CENTERED MANAGEMENT OF ALZHEIMER'S DISEASE. PAT SUMMIT FOUNDATION: RESTRICTED GRANT TO PAT SUMMITT CLINIC AT THE UNIVERSITY OF TENNESSEE MEDICAL CENTER FOR RESEARCH TO TREAT, PREVENT, CURE, AND ULTIMATELY ERADICATE ALZHEIMER'S DISEASE AT THE PAT SUMMITT CLINIC.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>1</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>206213</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>66666</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>272879</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 7</FormAndLineReferenceDesc>
        <ExplanationTxt>IN 2017, THE PRESIDENT/CEO, KENT KAROSEN, WAS AWARDED A BONUS OF $66,666 IN RECOGNITION OF HIS EXCELLENT PERFORMANCE DIRECTING THE INITIATIVES OF THE FOUNDATION, AND THE SENIOR VICE PRESIDENT. CORY RYAN. WAS AWARDED A BONUS OF $10,000. THE BONUSES WERE PROVIDED AT THE DISCRETION OF THE BOARD'S COMPENSATION COMMITTEE BY A UNANIMOUS VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>CENTURY BANK</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>SEE PART V</RelationshipDescriptionTxt>
        <TransactionAmt>6568632</TransactionAmt>
        <TransactionDesc>SEE PART V</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE L, PART IV</FormAndLineReferenceDesc>
        <ExplanationTxt>RESULTING FROM HIGHLY COMPETITIVE RATES OFFERED BY CENTURY BANK, THE FOUNDATION HOLDS $6,568,632 IN CERTIFICATES OF DEPOSIT WITH CENTURY BANK, WHERE MR. BARRY SLOANE (THE FOUNDATION'S CHAIRMAN/TREASURER) SERVES AS PRESIDENT AND CEO. MR. BARRY SLOANE AND HIS FAMILY MEMBERS OWN MORE THAN 35% OF THE TOTAL COMBINED VOTING POWER OF THE CENTURY BANK. THE ENTIRE BOARD WAS MADE AWARE OF THE CONFLICT WITH MR. SLOANE BEFORE THE CD INVESTMENTS WERE MADE AS WELL AS A CONTINUING DISCLOSURE AT ALL SUBSEQUENT BOARD MEETINGS. THE BOARD UNANIMOUSLY VOTED TO APPROVE THE INVESTMENTS. MR. SLOANE RECUSED HIMSELF FROM THE VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>16</ContributionCnt>
        <NoncashContributionsRptF990Amt>98398</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>AVG SELLING PRICE</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <Form8283ReceivedCnt>0</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>0</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, COLUMN (B):</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION IS REPORTING THE NUMBER OF DONORS ON PART I, LINE 9, COLUMN (B).</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART I, LINE 1</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S FUNDING AND ACTIVITIES ARE DIRECTED TOWARDS THE CAUSE, CARE &amp; CURE OF ALZHEIMER'S DISEASE. THE FOUNDATION FUNDS RESEARCH INTO THE CAUSE AND CURE OF ALZHEIMER'S DISEASE AT THE FISHER CTR FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIV., UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD,WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS. IT ALSO FUNDS PROJECTS FOR THE CARE OF PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR CAREGIVERS AT THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM AT THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE, UNDER THE DIRECTION OF BARRY REISBERG,MD., PROVIDING NON-PHARMACOLOGICAL TREATMENT OPTIONS TO IMPROVE CARE OF PEOPLE WITH ALZHEIMER'S. THE FOUNDATION PROVIDES EDUCATION &amp; INFORMATION TO THE PUBLIC THROUGH ITS WEBSITE WWW.ALZINFO.ORG, ITS PERIODIC MAGAZINE,PRESERVING YOUR MEMORY, AND A BI-WEEKLY E-NEWSLETTER OF THE LATEST EXPERT-REVIEWED RESEARCH FINDINGS ON CARE AND POSSIBLE TREATMENTS FOR ALZHEIMER'S.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>KENT KAROSEN IS A PARTNER AND EMPLOYEE OF CANTOR FITZGERALD, L.P. AND HE AND HIS ENTITIES, INCLUDING KAROSEN STRATEGIC PARTNERS, HAVE PROVIDED CONSULTING AND OTHER SERVICES FROM TIME TO TIME FOR HOWARD W. LUTNICK AND THE CANTOR ENTITIES. MR. LUTNICK ALSO SERVES AS TRUSTEE FOR CERTAIN OF MR. KAROSEN'S TRUSTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE 990 IS INITIALLY REVIEWED BY MEMBERS OF THE AUDIT COMMITTEE THAT CONSISTS OF 3 INDEPENDENT TRUSTEES. A COPY OF THE 990 IS THEN FORWARDED ELECTRONICALLY VIA EMAIL TO ALL BOARD MEMBERS AND RELEVANT MANAGEMENT PERSONNEL FOR THEIR REVIEW AND COMMENT BEFORE THE 990 IS FILED. IF ANY REVISIONS ARE REQUIRED, THEY ARE MADE AND THE REVISED 990 IS RESUBMITTED TO ALL BOARD MEMBERS FOR FINAL REVIEW BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A CONFLICT OF INTEREST POLICY WHICH IS ANNUALLY MONITORED REQUIRING ALL TRUSTEES TO DISCLOSE ANY POSSIBLE CONFLICT OF INTEREST VIA EMAIL RESPONSE TO THE SENIOR VICE PRESIDENT. THE FOUNDATION REQUIRES THAT ALL TRUSTEES, OFFICERS, KEY EMPLOYEES AND STAFF PERSONNEL PROMPTLY AND FULLY DISCLOSE ALL MATERIAL FACTS OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST THAT MAY EXIST AT THE TIME THE TRUSTEE IS APPOINTED OR STAFF PERSONNEL IS HIRED, OR AS THEY MAY ARISE WHILE THE TRUSTEE IS SERVING ON THE BOARD OR THE STAFF PERSONNEL IS EMPLOYED BY THE FOUNDATION. SUCH DISCLOSURES INVOLVING A TRANSACTION, ARRANGEMENT OR DECISION BEING CONSIDERED BY THE BOARD ARE MADE KNOWN TO ALL TRUSTEES. THE BOARD THEN DETERMINES WHETHER A CONFLICT OF INTEREST EXISTS WITH THE INTERESTED PARTY ABSTAINING FROM THE DECISION. IF IT IS DETERMINED THAT NO CONFLICT EXISTS, THEN THE BOARD VOTES ON THE TRANSACTION BUT WITH THE INTERESTED PARTY RECUSING HIMSELF FROM THE DISCUSSION AND VOTE ON SAID MATTER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A COMPENSATION COMMITTEE CONSISTING OF 4 INDEPENDENT TRUSTEES TO DETERMINE THE COMPENSATION OF THE PRESIDENT/CEO, SENIOR VICE PRESIDENT AND TOP MANAGEMENT AND KEY EMPLOYEES AT LEAST ONCE A YEAR.THE COMMITTEE IS MANDATED BY ITS CHARTER TO REVIEW EXECUTIVE AND OTHER KEY EMPLOYEE PERFORMANCE CONSISTENT WITH THE GOALS AND OBJECTIVES OF THE FOUNDATION AS DETERMINED BY THE BOARD OF TRUSTEES AND TO DETERMINE AN APPROPRIATE LEVEL OF COMPENSATION IN LIGHT OF THIS PERFORMANCE REVIEW AND USING OTHER SUBSTANTIATING DATA SURVEYS ON CURRENT COMPENSATION RATES FOR SIMILAR POSITIONS IN OTHER COMPARABLE NONPROFITS IN THE NEW YORK CITY AREA.THE COMMITTEE'S DECISION IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT (COMPENSATION COMMITTEE MINUTES) INDICATING THE DATE OF THE MEETING, THE MEMBERS PRESENT, AND THE COMPARABLE DATA USED TO MAKE THE DECISION.THE COMPENSATION REVIEW PROCESS FOR THE PRESIDENT/CEO AND EXECUTIVE VICE PRESIDENT WAS LAST UNDERTAKEN ON DECEMBER 15, 2017.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MAKES ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE BY POSTING IT ON THEIR WEBSITE AS WELL AS OTHER SIMILAR WEBSITES SUCH AS WWW.GUIDESTAR.ORG. IN ADDITION, THE FORM 990 AND AUDITED FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER POLICIES ARE AVAILABLE UPON WRITTEN REQUEST AT 110 E. 42ND STREET, FL 16, NEW YORK, NY 10017 OR BY CALLING THE ORGANIZATION DIRECTLY AT (800) 259-4636 OR (212) 915-1321.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9:</FormAndLineReferenceDesc>
        <ExplanationTxt>UNCOLLECTIBLE PLEDGES -80,150.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS AN AUDIT COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>